Story description (CNN Money): Ned Sahin is founder and CEO of neurotechnology start-up Brain Power, whose tool “Empower Me” uses smart glasses like Google Glass to coach those with autism. It helps schoolchildren learn social and cognitive skills and can even guide adults through an interview process. Brain Power’s product is sold to many schools in the U.S. but may never make it to market in Switzerland [Read more…] about Debate: What are the ethics of discouraging much-needed innovation given potential privacy concerns?
Is This the Future of Mental Health? (USC Viterbi School of Engineering):
“Brain–machine interfaces (BMIs) provide a direct pathway to the brain to translate brain signals into actions … Below, Shanechi (Note: Maryam Shanechi, PhD, assistant professor of electrical and computer engineering) answers some questions about her work and what the future might hold for our understanding and treatment of mental disorders.
What potential does this hold for the future not just of mental health, but of understanding our brains as a whole?
Neuropsychiatric disorders are a major cause of disability worldwide with depressive disorders being the most disabling among them. About 30% of major depression patients are treatment-resistant – that’s about 5 million people in the US alone. [Read more…] about Neuroengineering meets neuroethics to address treatment-resistant depression
Ana Maiques, CEO and founder of neurotech company Neuroelectrics, writes up a compelling case in her recent article, summarized thus:
“I strongly believe that Neurotech entrepreneurs can not afford not to be involved in neuroethics. It is simply not an option anymore.”
I share that belief and would like to take it one step further:
“I strongly believe that healthcare practitioners, researchers, executives and regulators can not afford not to be involved in neuroethics. It is simply not an option anymore.”
We hope you enjoy this slidedeck supporting a great session at the 2019 SharpBrains Virtual Summit: The Future of Brain Health (March 7–9th). Full recordings are available for purchase here.
1–2.30pm. How to address privacy, ethical and regulatory issues: Examples in cognitive enhancement, depression and ADHD
- Dr. Karen Rommelfanger, Director of the Neuroethics Program at Emory University
- Dr. Anna Wexler, Assistant Professor at the Perelman School of Medicine at UPenn
- Jacqueline Studer, Senior VP and General Counsel of Akili Interactive Labs
- Chaired by: Keith Epstein, Healthcare Practice Leader at Blue Heron
Wearable brain devices sold with questionable claims (Computer World):
“Wearable ‘neurotechnology’ devices have in recent years hit the mainstream market; pitched to consumers as a way to improve memory and attention, boost brain fitness and control games and objects with the power of the mind.
An analysis of commercially available wearable ‘neurodevices’ published this week in journal Neuron has cast doubt on whether their makers can back up such claims. [Read more…] about Study: Few wearable neurotechnologies have been directly tested by high-quality, peer-reviewed research
“The marketing of direct-to-consumer “neurotechnologies” can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or “read” one’s emotional state. However, many of these increasingly popular products aren’t fully supported by science and have little to no regulatory oversight, which poses [Read more…] about Bioethicists call for stronger oversight of direct-to-consumer neurotechnologies